NCT05464810 2025-05-23
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer
Emory University
Phase EARLY_PHASE1 Recruiting
Clinical Trials
9 trialsNCT03962647 2024-10-15
A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Completed
NCT05238831 2024-01-23
SMMART Adaptive Clinical Treatment (ACT) Trial
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Withdrawn
NCT02538484 2023-07-17
Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects
The University of Texas Health Science Center at San Antonio
Phase EARLY_PHASE1 Completed
NCT04130152 2022-10-25
PROMETEO II
SOLTI Breast Cancer Research Group
Phase EARLY_PHASE1 Completed
NCT04102618 2022-08-15
AWARE-1
Oncolytics Biotech
Phase EARLY_PHASE1 Terminated
NCT04630210 2022-06-15
AteBrO
Universitaire Ziekenhuizen KU Leuven
Phase EARLY_PHASE1 Withdrawn
NCT00651976 2018-10-15
Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Terminated
NCT02802748 2018-09-20
Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA)
SOLTI Breast Cancer Research Group
Phase EARLY_PHASE1 Completed